June 22, 2021
Euclid Systems Corp. recently launched Euclid MAX orthokeratology lenses. The FDA-approved lenses offer patients the highest oxygen permeability of any U.S. overnight OrthoK option without compromising on lens stability and performance.
In this video, Review of Myopia Management’s Editor-in-Chief John Sailer spoke with Jane Beeman, Euclid’s Director of Global Clinical and Scientific Affairs, and Dr. Trevor Fosso and Dr. Thanh Mai, both of whom have had the opportunity to fit young myopic patients with the Euclid MAX lenses over the last year. The optometrists shared their in-office experiences with the new lenses, including patients’ comfort levels, the overall durability of the lenses, and the benefits they’ve seen since switching patients over to the Euclid MAX lenses. Beeman also discussed the innovative technology behind Euclid MAX that has made it such a successful treatment option for patients with myopia.
Watch the full video to learn more about the Euclid MAX OrthoK lenses.
This presentation expresses the opinions and use of contact lens products as utilized by licensed eye care doctors. It may not reflect the FDA definition for orthokeratology or the specific approved use of Euclid products.